Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab

Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab

Purpose: The aim of this study was to evaluate the efficacy and safety of Razumab (the biosimilar Ranibizumab by Intas Pharmaceuticals Ltd.) for the treatment of chorioretinal vascular diseases such as diabetic macular edema (DME), choroidal neovascular membrane (CNVM), and macular edema secondary t...

Full description

Bibliographic Details
Main Authors: Lalit Verma, Mithun Thulasidas, Ajay Purohit, Avnindra Gupta, Ritesh Narula, Dinesh Talwar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Ophthalmology
Subjects:
biosimilar ranibizumab
choroidal neovascular membrane
diabetic macular edema
razumab
retinal vein occlusion
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=2;spage=347;epage=351;aulast=Verma

Internet

http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=2;spage=347;epage=351;aulast=Verma

Similar Items